~~<i id='74D82FF906'><strike id='74D82FF906'><tt id='74D82FF906'><pre id='74D82FF906'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：knowledge 2025-09-30 21:58:19 - browse：93149

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

However, some outside experts expressed skepticism about the result.

Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin — is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： ActiGraph execs on goal of drug approvals with digital endpoints

hotspot

focus

leisure time

focus

hotspot

knowledge

JeremeyWyattActiGraphAsdrugmakerswadeintousingdigitalhealthtechnologies,ActiGraphhasmadeitsmissionto

WSS

CDC wastewater surveillance dashboard to track bird flu hotspots

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Liz Cheney makes 1st public comment since Trump's election interference indictments

Hilary may become 1st tropical storm to make landfall in California in 84 years

What nurses really want: sufficient staffing for patient care

Clinical trials must include more disabled people

focus

hotspot

hotspot

New air purifier tech could be key to improving indoor air quality

Researchers on aging grapple with how to calculate biological age

Alkermes shareholders re

Hilary may become 1st tropical storm to make landfall in California in 84 years

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves first treatment for ultra

Trump demands the U.S. pay no more for drugs than other countries … again

ActiGraph execs on goal of drug approvals with digital endpoints

Hepatitis C has a cure — but many Americans still lack access to it

First recipient of genetically engineered pig kidney has died

focus

Telehealth startups turn to complex chronic diseases

Making AI in medicine accessible to smaller, and rural hospitals

Elevance, private equity launch primary care company

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

First recipient of genetically engineered pig kidney has died

leisure time

focus

hotspot

knowledge